← Back to Search

Meal Replacement

Tality for Prostate Cancer

N/A
Waitlist Available
Led By Randall S Stafford, MD, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Males >= age 18.
All patients must have a life expectancy of > 6 months.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This trial will see if a meal replacement is satisfying and tolerable for men with prostate cancer. Participants will get meal replacements as their only source of nutrition for 4 weeks. The purpose is to test whether the meal replacements are suitable to be used in larger studies of patients with cancer.

Eligible Conditions
  • Prostate Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of Completers
Secondary outcome measures
Change in Prostate Specific Antigen
Body Weight Changes
Change in weight from baseline

Trial Design

1Treatment groups
Experimental Treatment
Group I: TalityExperimental Treatment1 Intervention
Participants will receive TalityTM as their sole intake for nutritional purposes for a 4 week period.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,374 Previous Clinical Trials
17,332,911 Total Patients Enrolled
22 Trials studying Prostate Cancer
3,970 Patients Enrolled for Prostate Cancer
Filtricine Inc.UNKNOWN
Randall S Stafford, MD, PhDPrincipal InvestigatorStanford Universiy
1 Previous Clinical Trials
207 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Mar 2025